GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences

Naturally occurring phytohormones have shown distinguished potential in chemoprevention and treatment of chronic inflammatory diseases in mammalian cells. Strigolactones (SLs) are a class of carotenoid-derived lactones regulating many aspects of plant development and recently recognized as phytohormones with promising anticancer activity. In this study, GR24, a synthetic analog and representative of SLs, induced the expression of phase II detoxifying enzymes such as HO-1 and NQO1 in hepatic and macrophage cell lines under normal and inflammatory conditions, respectively. This effect has been found to be mediated by Nrf2 activation. In silico molecular docking against 16-mer peptide binding site on Keap1 suggested that GR24 may exert its biological activity by interfering with Keap1 and Nrf2 binding. GR24 also displayed remarkably potent inhibitory activity against the production of nitric oxide (NO) and molecular docking analysis on iNOS supported experimental data. Furthermore, GR24 dose dependently suppressed the LPS-induced iNOS expression at both mRNA and protein level. It also significantly decreased IL-1β release, mRNA expression of IL-1β and COX-2, as well as nuclear accumulation of NFҡB at the low micro molar range in LPS-stimulated murine macrophages. GR24 promoted AKT activation in insulin resistant skeletal muscle cells and downregulated the expression of enzymes, PEPCK and G6Pase control the rate limiting steps of gluconeogenesis in hepatic cells. The results of molecular docking and ADMET analyses indicated that GR24 might be classified as druggable molecule in drug design. Taken together, all results suggest that SLs can be promising multi-potent botanical leads for the mitigation of inflammatory-mediated chronic disorders.

[1]  R. Weiss,et al.  Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[2]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[3]  S. Gygi,et al.  S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction , 2015, Science.

[4]  R. Yarden,et al.  Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model , 2015, Cancer biology & therapy.

[5]  I. Raskin,et al.  Hypoglycemic effects of brassinosteroid in diet-induced obese mice. , 2012, American journal of physiology. Endocrinology and metabolism.

[6]  F. Gossé,et al.  Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats. , 2000, Nitric oxide : biology and chemistry.

[7]  T. Tumer,et al.  Inhibitory Effects of Spirulina platensis on Carcinogen-Activating Cytochrome P450 Isozymes and Potential for Drug Interactions , 2013, International journal of toxicology.

[8]  T. Kensler,et al.  NRF2 as an Emerging Therapeutic Target , 2017, Oxidative medicine and cellular longevity.

[9]  Mark P. Mattson,et al.  NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .

[10]  R. Yarden,et al.  Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells. , 2014, Oncotarget.

[11]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[12]  C. Rao,et al.  Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. , 1999, Carcinogenesis.

[13]  Hong Zhao,et al.  Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer , 2015, Breast Cancer Research.

[14]  E. Arinç,et al.  The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping , 2010 .

[15]  I. Raskin,et al.  Direct and indirect antioxidant activity of polyphenol- and isothiocyanate-enriched fractions from Moringa oleifera. , 2015, Journal of agricultural and food chemistry.

[16]  Seda Savranoglu Kulabas,et al.  Aryl benzofuran derivatives from the stem bark of Calpocalyx dinklagei attenuate inflammation. , 2017, Phytochemistry.

[17]  B. Zwanenburg,et al.  Strigolactones: new plant hormones in the spotlight. , 2018, Journal of experimental botany.

[18]  J. Sharifi‐Rad,et al.  Natural Products and Synthetic Analogs as a Source of Antitumor Drugs , 2019, Biomolecules.

[19]  M. Ay,et al.  Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti‐inflammatory activity , 2017, International immunopharmacology.

[20]  Wei-Min Chen,et al.  Strigolactones: a plant phytohormone as novel anti-inflammatory agents. , 2018, MedChemComm.

[21]  Miroslav Strnad,et al.  Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells. , 2010, Chemico-biological interactions.

[22]  Karen Brown,et al.  Clinical trials of resveratrol , 2011, Annals of the New York Academy of Sciences.

[23]  T. Kensler,et al.  When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.

[24]  Shan-shan Wu,et al.  Occurrence, function and potential medicinal applications of the phytohormone abscisic acid in animals and humans. , 2011, Biochemical pharmacology.

[25]  B. Dieter.  Dysregulation of Nrf2 Signaling in Diabetes: An Opportunity for a Multitarget Approach , 2015 .

[26]  L. Magnelli,et al.  Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. , 2003, The American journal of pathology.

[27]  Y. Pommier,et al.  Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair , 2016, Oncotarget.

[28]  D. Heo,et al.  The effect of nitric oxide on cyclooxygenase‐2 (COX‐2) overexpression in head and neck cancer cell lines , 2003, International journal of cancer.

[29]  M. Wall,et al.  Germination of Witchweed (Striga lutea Lour.): Isolation and Properties of a Potent Stimulant , 1966, Science.

[30]  S. Kanda,et al.  Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity. , 2014, Translational research : the journal of laboratory and clinical medicine.

[31]  Yajing Wang,et al.  Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation. , 2014, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[32]  B. Lacombe,et al.  Plant Hormones: Key Players in Gut Microbiota and Human Diseases? , 2017, Trends in plant science.

[33]  Guodong Wang,et al.  Strigolactone-triggered stomatal closure requires hydrogen peroxide synthesis and nitric oxide production in an abscisic acid-independent manner. , 2018, The New phytologist.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  Ö. Tulunay,et al.  Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low‐ and high‐grade prostatic intraepithelial neoplasia and prostatic carcinoma , 2001, BJU international.

[36]  Giovanni Scalmani,et al.  Gaussian 09W, revision A. 02 , 2009 .

[37]  Hong Zhu,et al.  NAD(P)H:Quinone Oxidoreductase 1 and its Potential Protective Role in Cardiovascular Diseases and Related Conditions , 2011, Cardiovascular Toxicology.

[38]  M. Laakso,et al.  Plant-derived compounds strigolactone GR24 and pinosylvin activate SIRT1 and enhance glucose uptake in rat skeletal muscle cells , 2017, Scientific Reports.

[39]  Mohammed Bouachrine,et al.  3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase , 2018, Comput. Biol. Chem..

[40]  D. Kalaitzidis,et al.  Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer , 2002 .

[41]  Y. Kapulnik,et al.  Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells , 2012, Breast Cancer Research and Treatment.

[42]  H. Matsuda,et al.  Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. , 2000, Bioorganic & medicinal chemistry letters.

[43]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[44]  Shinjiro Yamaguchi,et al.  Contribution of Strigolactones to the Inhibition of Tiller Bud Outgrowth under Phosphate Deficiency in Rice , 2010, Plant & cell physiology.

[45]  A. Dinkova-Kostova,et al.  The "Prochaska" microtiter plate bioassay for inducers of NQO1. , 2004, Methods in enzymology.

[46]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[47]  D. Giugliano,et al.  The metabolic syndrome and inflammation: association or causation? , 2004, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[48]  K. Akiyama,et al.  Plant sesquiterpenes induce hyphal branching in arbuscular mycorrhizal fungi , 2005, Nature.

[49]  J. Coombes,et al.  Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? , 2016, Oxidative medicine and cellular longevity.

[50]  M. López-Climent,et al.  The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation , 2016, Nutrition & Metabolism.

[51]  T J Campbell,et al.  HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.

[52]  Muhammad Ilyas,et al.  In silico identification of novel IL-1β inhibitors to target protein-protein interfaces , 2015, Comput. Biol. Chem..

[53]  Caroline Gutjahr,et al.  Strigolactone Signaling and Evolution. , 2017, Annual review of plant biology.

[54]  H. Ohshima,et al.  Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. , 2001, Cancer research.

[55]  Y. Soini,et al.  Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  B. Salehi,et al.  Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications , 2019, Molecules.

[57]  F. Abas,et al.  Biological Evaluation of Curcumin and Related Diarylheptanoids , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[58]  F. Bosch,et al.  Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. Madsen,et al.  Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetes , 2001 .

[60]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .